Although academic researchers have the knowledge and skills to develop potentially life changing products for patients, they often face unique challenges compared to other founders. Lengthy and expensive R&D costs often make VCs hesitant to invest. While spinoff founders are experts in their field, they often lack the necessary skills to build a successful startup, particularly in sales and business management. Finally, regulations and certifications often make it difficult to get solutions into the hands of the patients who need them most. According to a recent report by Techleap.nl, the Netherlands in particular is lagging behind other European countries when…
This story continues at The Next WebRead More